Authors/Disclosures
|
Nicolas Dupre, MD, FAAN
(CHU de Quebec - U Laval)
|
Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation. |
|
Alexandra Muccilli, MD
(Saint Michael's Hospital - Multiple Sclerosis Clinic)
|
Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Muccilli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. |
|
Robert Davis
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Steve Verreault, MD
(Hopital De L'Enfant-Jesus)
|
The institution of Dr. Verreault has received research support from BMS. The institution of Dr. Verreault has received research support from Portola. The institution of Dr. Verreault has received research support from Daichii Sankyo. |
|
Daniel H. Lachance, MD, FAAN
(Mayo Clinic)
|
Dr. Lachance has nothing to disclose. |
|
Laure Michel
|
No disclosure on file |
|
Jean-Pierre Bouchard, MD, FAAN
|
No disclosure on file |
|
|
No disclosure on file |
|
Guy A. Rouleau, MD, PhD, FAAN
(Montreal Neurological Institute and Hospital)
|
Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma. |
|
Catherine Larochelle, MD
(CRCHUM)
|
Dr. Larochelle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Novartis, Sanofi-Genzyme, Alexion, EMD-Serono, FIND therapeutics, Actelion. The institution of Dr. Larochelle has received research support from Université de Montréal-CHUM. |
|
Alexandre Prat, MD
(CHUM Hopital Norte Dame/ Dept of Neurology)
|
The institution of Dr. Prat has received research support from CIHR and MSSC. |
|
Mohit Neema, MD
|
No disclosure on file |